Endo Pharmaceuticals Holdings Wire
Comprehensive News Feed for Endo Pharmaceuticals Holdings.
Results 1 - 20 of 129 in Endo Pharmaceuticals Holdings
-
Stocks: How Phila. firms are faring
... Soup (NYSE:CPB) - up .06 percent at $33.82. Cephalon (NYSE:CEPH) - up 1 percent at $63.03. Endo Pharmaceuticals Holdings (NASDAQ:ENDP) - up 2.6 percent at $21.06. Pep Boys - Manny, Moe & Jack (NYSE:PBY) - up .35 percent at $8.49. Tasty Baking Co. ... Comment?
-
News and FDA Updates for Compugen
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions. Comment?
-
Endo Pharmaceuticals today announced that it will present at the J.P. Morgan 28th Annual Healthcare Conference on Wednesday, Jan. Comment?
-
LecTec issues open letter to shareholders on companya s current developments
LecTec Corporation announced today that it has issued the following open letter from Judd Berlin, the Chief Executive Officer of LecTec, to its shareholders regarding current developments at the Company: December 22, 2009 Dear Shareholders of LecTec: Today your company is in the best condition ever in its 32-year history. Comment?
-
LecTec Corporation Releases Open Letter to Shareholders
LecTec Corporation announced today that it has issued the following open letter from Judd Berlin, the Chief Executive Officer of LecTec, to its shareholders regarding current developments at the Company: December 22, 2009 Dear Shareholders of LecTec: Today your company is in the best condition ever in its 32-year history. Comment?
-
Hopes fade for HIV microbicide
The failure of the PRO 2000 gel is part of a decade-long history of unsuccessful attempts to develop vaginal microbicides, which many researchers see as the most effective way to protect women from HIV infection in the developing world. Comment?
-
AIDS virus "prevention" gel fails in African trials
" U.S. drug firm Endo Pharmaceuticals' gel designed to prevent infection with the AIDS virus has proved ineffective in trials in Africa, Britain's Medical Research Council said on Monday. Comment?
-
AIDS Prevention Gel Fails in African Trials
w/Photo
U.S. drug company Endo Pharmaceuticals' gel designed to prevent infection with the AIDS virus was ineffective in trials in Africa, Britain's Medical Research Council said on Monday. Comment?
-
Aids gel failure another setback for Endo
By Kate Kelland US drug firm Endo Pharmaceuticals' gel designed to prevent infection with the AIDS virus has proved ineffective in trials in Africa, Britain's Medical Research Council said on Monday. Comment?
-
By Kate Kelland London - United States drug company Endo Pharmaceuticals' gel designed to prevent infection with HIV was ineffective in trials in Africa, Britain's Medical Research Council said on Monday. Comment?
-
AIDS virus "prevention" gel fails in African trials
Indonesian volunteers light candles during a ceremony to mark World AIDS Day in Jakarta on December 1, 2009 in a file photo. Comment?
-
Aids gel failure another setback for Endo
By Kate Kelland US drug firm Endo Pharmaceuticals' gel designed to prevent infection with the AIDS virus has proved ineffective in trials in Africa, Britain's Medical Research Council said on Monday. Comment?
-
AIDS 'prevention' gel fails in African trials new
A gel made by US drug firm Endo Pharmaceuticals that is designed to prevent infection with the AIDS virus has proved ineffective in trials in Africa, Britain's Medical Research Council said today. Comment?
-
Two people died and three others were injured when a car overturned in Faure, Cape Town, paramedics said on Monday. Comment?
-
Blood service wage dispute at CCMA
Arbitration over a wage dispute at the SA National Blood Service was under way on Monday, the Health and Other Service Personnel Trade Union of SA said. Comment?
-
Vertex Pharmaceuticals Announces Appointment of Nancy J. Wysenski as Chief Commercial Officer
Vertex Pharmaceuticals Incorporated today announced the appointment of Nancy J. Wysenski as Executive Vice President and Chief Commercial Officer. Comment?
-
FedEx: Analysts' Upgrades, Dowgrades
CHANGE IN RATINGS Apple initiated at Calyon Securities with a Buy rating and $260 price target. Comment?
-
Endo Pharma downgraded on drug delay
An Oppenheimer analyst downgraded shares of Endo Pharmaceuticals Holdings Inc. Monday, pointing to regulatory delays for two of Endo's testosterone drug candidates. Comment?
-
Endo Pharmaceuticals Provides Regulatory Update on Aveed (Testosterone Undecanoate) Injection
Endo Pharmaceuticals today announced that it received a complete response letter from the U.S. Food and Drug Administration regarding the New Drug Application for its extended-duration testosterone undecanoate injection, Aveed, for men diagnosed with low testosterone. Comment?
-
Analyst upgrades, downgrades and initiations: CMCSA, MRVL, NFLX, RAI, TTWO, V ...
Filed under: Analyst reports , Analyst upgrades and downgrades , Analyst initiations , Visa Inc. Comment?
Endo Pharmaceuticals Holdings Forum
| Topic | Comments |
|---|---|
| Endo gets painkiller approval | 2 |
| Endor Pharma jumps on FDA approvals | 4 |
Most Popular
- Gay couple 'angry' at Boy Scout decision - 442 comments
- Limbaugh's health hypocrisy on display. - 454 comments
- Obama, it's game on now - 232 comments
- Why are most Black women soo big? - 121 comments
- Ron Paul "They're Terrorists Because We're Occupiers" - 187 comments
- Black women doomed? - 176 comments
- President Obama Orders a 'Snowbama' - 90 comments
- Saddleback Church Pastor Rick Warren admits cash problems - 84 comments
- Soap airs daytime's first gay sex scene - 48 comments
- Sen. John Kerry undergoing 2nd hip replacement - 55 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
